Abstract

This paper provides a new insight into the fundamentals of plasma medicine: The definition of “plasma dose.” Based on the dominant role of reactive oxygen nitrogen species (RONS) in plasma biological effects, we first propose the equivalent total oxidation potential (ETOP) as the definition of plasma dose. The ETOP includes three parts: the item H, which is the ETOP of the RONS generated by plasma; the item T, which is associated with the reactive agents unrelated to RONS, such as UV/vacuum ultraviolet (VUV) emission of plasma; and the item f(H,T), which is related to the synergistic effects between H and T factors. To evaluate the feasibility of the ETOP as a plasma dose, the bacterial reduction factor (BRF), which is the log reduction of bacteria colony-forming units, is selected as the indicator of the plasma biological effect. A model establishing the relationship between the ETOP and BRF is presented. For the first try of this paper, a linear relationship between the lgETOP and BRF is assumed. The model is initially validated by the published data from the literature. Further simulation and experiment are also conducted, and the positive correlation between the ETOPs and BRFs in the model again suggests that the ETOP could be a reasonable solution as the plasma dose. Finally, the prospects for improving the ETOP, such as including RONS generated in liquid phase, evaluating the weight factor of each type RONS, and involving the effect of electrons, ions, and UV/VUV, are discussed.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.